Heterogeneity in the stimuli, genetic predisposition and diverse signalling mechanisms that promote profibrotic cell phenotypes may also contribute to the difference in PD-1 expression between patients with asbestosis, silicosis and IPF. This evidence concerns the gene PDCD1 and silicosis.